Una Ryan

Management Sciences for Health, Inc. provides healthcare services. The company was founded by Ronald O’Connor in 1971 and is headquartered in Medford, MA.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

Astia Angels (Astia Angels) is a venture capital subsidiary of Astia, Inc, founded in 2013. The firm is headquartered in San Francisco, California.

Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Cambridge in America provides alumni network relations services. They help build a community of Cambridge University alumni and friends throughout the United States. The company was founded in 2000 and is headquartered in New York, NY.

Elemental Machines, Inc. provide intelligent technology for the smart lab. Its products include synthetic biology, drug discovery, genomic testing and materials sciences. The company was founded by Sridhar Iyengar, Elicia Wong and Gary Tsai in 2014 and is headquartered in Cambridge, MA.

Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA.

MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA.

IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA.

Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA.

Bioarray Genetics, Inc. develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments. It also develops proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used. The company was founded by Marcia Fournier and Katherine J. Martin in 2009 and is headquartered in Farmington, CT.

Breakout Ventures LP seeks investment opportunities in companies located in the US. The fund targets the companies operating in the fields of technology, biology, materials and energy. It provides financing for early stage capital requirement.

Lionheart Ventures Fund invests in profitable middle-market industrial & technology companies located in the US. The fund focuses on companies with an EBITDA of $1 - $10 million, revenues of $5 - $50 million and strong management team. It targets companies operating in the fields of niche industrial manufacturers, engineered product companies, sensors & controls, precision mechanical components, automotive, aerospace/defense, pumps, valves & mixers and other general industrial markets. It provides financing for acquisitions, add-on acquisitions and turnaround situations.

Golden Seeds LLC (Golden Seeds) is a venture capital firm founded in 2005 by Stephanie Hanbury-Brown. The firm is headquartered in New York city with an additional offices in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, New York and Silicon Valley.

EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA.